Impact of prenatal alcohol exposure on adult health outcomes
Summary
The purpose of this study is to learn more about how health problems faced by adults with fetal alcohol spectrum disorder (FASD) differ from those of adults without FASD. The study involves completing questionnaires about your health/mental health, background information, and school/work details. You will also be asked to complete some assessments on an iPad/computer and provide a small blood sample and a small fecal (poop) and salive sample (both collected at home). The study will take approximately 6 hrs of your time (2.5 hrs required in person) and you will be compensated with a gift card for your participation.
Eligibility
Eligible ages: 19 to 99
Accepts healthy participants: Yes
Inclusion criteria:
1) 19+ years old
2) Able to communicate in English
3) Generally healthy and able to complete the study questionnaires/assessments
Exclusion criteria:
1) Non-correctable vision or hearing impairment
2) HIV+
3) Mental or physical illness preventing participating in study activities
4) Currently pregnant
5) Unable to communicate in English
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Dr. Tamara Bodnar
Principal investigator:
Tamara Bodnar
Clinical trial:
No
REB-ID:
REB23-0795